CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to SNY

Fitusiran

Phase 3
Sanofi (SNY)

Phase 3

Development Phase

0

Upcoming Catalysts

1

Historical Events

0

Regulatory Approvals

Development History
Sep '26
SNYPhase 3

Fitusiran Phase 3 Est. Readout

Fitusiran
Sep 2026~
CT.gov
00%
Competitive Landscape

2 competitors in Hemophilia

View Full Landscape
Drug Information

Target Indication

Hemophilia

Clinical Trial

NCT03754790

Last updated: 12/8/2025

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.